KNSA:NASDAQ, Kiniksa Pharmaceuticals International, plc

KNSA stock overview

Kiniksa Pharmaceuticals International, plc (KNSA:NASDAQ) closed at $76.73 on October 23, 2026, down 5.03% on the day. The stock trades 8.7% below its 52-week high of $84.06 and 118.0% above its 52-week low of $35.20. Over the past year, it gained 97.1%. Kiniksa Pharmaceuticals International, plc is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price: $76.73
Day change: -5.03%
Volume: 574,652
Average volume: 608,667
Market cap: 5B+
52-week range: $35.20 – $84.06
50-day average: $78.13
200-day average: $58.82

Price action over the past year

In 252 trading sessions since October 23, 2025, KNSA closed higher on 134 days (53%). Its best day was July 28, 2026 (+25.03%) and its worst was February 24, 2026 (-8.21%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

Oct 23, 2026: Hit a new 2-Week Low of $76.73 (New Highs/Lows scanner)
Oct 23, 2026: Trading sideways between $74.61 and $83.17 over 30 days (Sideways scanner)
Oct 22, 2026: News catalyst: Earnings (News Catalysts scanner)

KNSA news

Oct 24, 2026: 3 Healthcare Stocks To Watch In October 2026
Oct 22, 2026: Kiniksa's Raised Outlook Implies A Bigger Third Quarter Than Wall Street Is Modeling
Oct 22, 2026: Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026
Oct 21, 2026: Dow Jones Futures: SpaceX, Supermicro Revive AI Stocks; Tesla, Meta On Deck
Oct 17, 2026: GeneDx Holdings And 2 Other Top Healthcare Stocks
Oct 14, 2026: Biotech Stocks To Watch: Regeneron Partner Has Breakout In Sight
Sep 23, 2026: Kiniksa Pharmaceuticals International (KNSA) On The ARCALYST Story And Whether Shares Look Fully Valued
Sep 17, 2026: Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why

About Kiniksa Pharmaceuticals International, plc

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.

Similar stocks

Find more stocks like KNSA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.